Identification of molecular determinants of primary and metastatic tumour re-initiation in breast cancer

Nature Cell Biology

Volumn 17, Issue 5, 2015, Pages 651-664

  Ross, Jason B ^a   Huh, Doowon ^a   Noble, Lisa B ^a   Tavazoie, Sohail F ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; LAMININ ALPHA4; FORKHEAD TRANSCRIPTION FACTOR; FOXQ1 PROTEIN, HUMAN; LAMA4 PROTEIN, HUMAN; LAMININ; NAP1L3 PROTEIN, HUMAN; NERVE PROTEIN; TUMOR MARKER;

ARTICLE; BREAST METASTASIS; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; FOXQ1 GENE; GENE INTERACTION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC MARKER; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LAMA4 GENE; MOLECULAR PATHOLOGY; NAP1L3 GENE; ONCOGENE; PREDICTION; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; TUMOR MICROENVIRONMENT; UPREGULATION; ANIMAL; BREAST TUMOR; CANCER STEM CELL; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION; GENETIC DATABASE; GENETIC PREDISPOSITION; GENETIC TRANSFECTION; GENETICS; LIVER TUMOR; LUNG TUMOR; METABOLISM; MICROMETASTASIS; NONOBESE DIABETIC MOUSE; PATHOLOGY; PHENOTYPE; RNA INTERFERENCE; SCID MOUSE; SECONDARY; SIGNAL TRANSDUCTION; TIME; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALS; ANTIGENS, CD29; BIOMARKERS, TUMOR; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DATABASES, GENETIC; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LAMININ; LIVER NEOPLASMS; LUNG NEOPLASMS; MICE, INBRED NOD; MICE, SCID; NEOPLASM MICROMETASTASIS; NEOPLASTIC STEM CELLS; NERVE TISSUE PROTEINS; PHENOTYPE; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; TUMOR BURDEN;

EID: 84928938542     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb3148     Document Type: Article

References (70)

1. Klein C. A. Parallel progression of primary tumours and metastases. Nat. Rev. Cancer 9, 302-312 (2009
2. Maheswaran S. & Haber D. A. Circulating tumor cells: a window into cancer biology and metastasis. Curr. Opin. Genet. Dev. 20, 96-99 (2010
3. Chiang A. C. & Massague J. Molecular basis of metastasis. N. Engl. J. Med. 359, 2814-2823 (2008
4. Fidler I. J. The pathogenesis of cancer metastasis: the' seed and soil 'hypothesis revisited. Nature Rev. Cancer 3, 453-458 (2003
5. Pavlova N. N., et al. A role for PVRL4-driven cell-cell interactions in tumorigenesis. eLife 2, e00358 (2013
6. Williams S. A., Anderson W. C., Santaguida M. T. & Dylla S. J. Patient-derived xenografts the cancer stem cell paradigm and cancer pathobiology in the 21st century. Lab. Invest. 93, 970-982 (2013
7. Shimono Y., et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138, 592-603 (2009
8. Visvader J. E. & Lindeman G. J. Cancer stem cells: current status and evolving complexities. Cell Stem Cell 10, 717-728 (2012
9. Chaffer C. L., et al. Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell 154, 61-74 (2013
10. Magee J. A., Piskounova E. & Morrison S. J. Cancer stem cells: impact heterogeneity and uncertainty. Cancer Cell 21, 283-296 (2012
11. Vanharanta S. & Massague J. Origins of metastatic traits. Cancer Cell 24, 410-421 (2013
12. Clark E. A., Golub T. R., Lander E. S. & Hynes R. O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406, 532-535 (2000
13. Kang Y., et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3, 537-549 (2003
14. Minn A. J., et al. Genes that mediate breast cancer metastasis to lung. Nature 436, 518-524 (2005
15. Pencheva N., et al. Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Cell 151, 1068-1082 (2012
16. Tavazoie S. F., et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451, 147-152 (2008
17. Png K. J., Halberg N., Yoshida M. & Tavazoie S. F. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature 481, 190-194 (2012
18. Putti T. C., et al. Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis. Mod. Pathol. 18, 26-35 (2005
19. Cailleau R., Olive M. & Cruciger Q. V. Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In vitro 14, 911-915 (1978
20. Bos P. D., et al. Genes that mediate breast cancer metastasis to the brain. Nature 459, 1005-1009 (2009
21. Rhim A. D., et al. EMT and dissemination precede pancreatic tumor formation. Cell 148, 349-361 (2012
22. Diehn M. & Majeti R. Metastatic cancer stem cells: an opportunity for improving cancer treatment?. Cell Stem Cell 6, 502-503 (2010
23. Brabletz T., Jung A., Spaderna S., Hlubek F. & Kirchner T. Opinion: migrating cancer stem cells-an integrated concept of malignant tumour progression. Nat. Rev. Cancer 5, 744-749 (2005
24. Brabletz T. EMT and MET in metastasis: where are the cancer stem cells?. Cancer Cell 22, 699-701 (2012
25. Padua D., et al. TGF β primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133, 66-77 (2008
26. Reymond N., d'Agua B. B. & Ridley A. J. Crossing the endothelial barrier during metastasis. Nat. Rev. Cancer 13, 858-870 (2013
27. Nguyen D. X., Bos P. D. & Massague J. Metastasis: from dissemination to organspecific colonization. Nat. Rev. Cancer 9, 274-284 (2009
28. Stenzel D., et al. Endothelial basement membrane limits tip cell formation by inducing Dll4/Notch signalling in vivo. EMBO Rep. 12, 1135-1143 (2011
29. Goering W., et al. Impairment of gastric acid secretion and increase of embryonic lethality in Foxq1-deficient mice. Cytogenet. Genome Res. 121, 88-95 (2008
30. Zhang H., et al. Forkhead transcription factor foxq1 promotes epithelialmesenchymal transition and breast cancer metastasis. Cancer Res. 71, 1292-1301 (2011
31. Attia M., et al. Interaction between nucleosome assembly protein 1-like family members. J. Mol. Biol. 407, 647-660 (2011
32. Buchstaller J., McKeever P. E. & Morrison S. J. Tumorigenic cells are common in mouse MPNSTs but their frequency depends upon tumor genotype and assay conditions. Cancer Cell 21, 240-252 (2012
33. Grassian A. R., Coloff J. L. & Brugge J. S. Extracellular matrix regulation of metabolism and implications for tumorigenesis. Cold Spring Harb. Symp. Quant. Biol. 76, 313-324 (2011
34. Aguirre-Ghiso J. A. Models mechanisms and clinical evidence for cancer dormancy. Nat. Rev. Cancer 7, 834-846 (2007
35. Polyak K., et al. p27Kip1, a cyclin-Cdk inhibitor links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8, 9-22 (1994
36. Zhu X., Ohtsubo M., Bohmer R. M., Roberts J. M. & Assoian R. K. Adhesiondependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J. Cell Biol. 133, 391-403 (1996
37. Harper J. W., Adami G. R., Wei N., Keyomarsi K. & Elledge S. J. The p21 Cdkinteracting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816 (1993
38. Geberhiwot T., et al. Laminin-8 (α 4β 11) is synthesized by lymphoid cells promotes lymphocyte migration and costimulates T cell proliferation. J. Cell Sci. 114, 423-433 (2001
39. Fujiwara H., Kikkawa Y., Sanzen N. & Sekiguchi K. Purification and characterization of human laminin-8. Laminin-8 stimulates cell adhesion and migration through-3-1 and-6-1 integrins. J. Biol. Chem. 276, 17550-17558 (2001
40. Kortesmaa J., Yurchenco P. & Tryggvason K. Recombinant laminin-8 (-(4)-(1)(1)). Production purification and interactions with integrins. J. Biol. Chem. 275, 14853-14859 (2000
41. Hohenester E. & Yurchenco P. D. Laminins in basement membrane assembly. Cell Adhes. Migration 7, 56-63 (2013
42. Moreno-Layseca P. & Streuli C. H. Signalling pathways linking integrins with cell cycle progression. Matrix Biol. 34, 144-153 (2014
43. Miranti C. K. & Brugge J. S. Sensing the environment: a historical perspective on integrin signal transduction. Nat. Cell Biol. 4, E83-90 (2002
44. Giancotti F. G. Mechanisms governing metastatic dormancy and reactivation. Cell 155, 750-764 (2013
45. Shibue T. & Weinberg R. A. Integrin 1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs. Proc. Natl Acad. Sci. USA 106, 10290-10295 (2009
46. Espina V. & Liotta L. A. What is the malignant nature of human ductal carcinoma in situ?. Nat. Rev. Cancer 11, 68-75 (2011
47. Lee S., et al. Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer. Cancer Res. 72, 4574-4586 (2012
48. Ma X. J., et al. Gene expression profiles of human breast cancer progression. Proc. Natl Acad. Sci. USA 100, 5974-5979 (2003
49. Ma X. J., Dahiya S., Richardson E., Erlander M. & Sgroi D. C. Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res. 11, R7 (2009
50. Schuetz C. S., et al. Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors combining laser capture microdissection and oligonucleotide microarray analysis. Cancer Res. 66, 5278-5286 (2006
51. Desmedt C., et al. Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin. Cancer Res. 13, 3207-3214 (2007
52. Hatzis C., et al. A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA 305, 1873-1881 (2011
53. van de Vijver M. J., et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347, 1999-2009 (2002
54. Wang Y., et al. Gene-expression profiles to predict distant metastasis of lymph-nodenegative primary breast cancer. Lancet 365, 671-679 (2005
55. Peduto L., et al. ADAM12 is highly expressed in carcinoma-associated stroma and is required for mouse prostate tumor progression. Oncogene 25, 5462-5466 (2006
56. Kessenbrock K., Plaks V. & Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141, 52-67 (2010
57. Goss P. E. & Chambers A. F. Does tumour dormancy offer a therapeutic target?. Nat. Rev. Cancer 10, 871-877 (2010
58. Nelson C. M. & Bissell M. J. Of extracellular matrix scaffolds and signaling: tissue architecture regulates development homeostasis and cancer. Annu. Rev. Cell Dev. Biol. 22, 287-309 (2006
59. Kusuma N., et al. Integrin-dependent response to laminin-511 regulates breast tumor cell invasion and metastasis. Int. J. Cancer 130, 555-566 (2012
60. Yurchenco P. D. Basement membranes: cell scaffoldings and signaling platforms. Cold Spring Harb. Perspect. Biol. 3, a004911 (2011
61. Fujita M., et al. Overexpression of-1-chain-containing laminins in capillary basement membranes of human breast cancer and its metastases. Breast Cancer Res. 7, R411-421 (2005
62. Hamill K. J., Kligys K., Hopkinson S. B. & Jones J. C. Laminin deposition in the extracellular matrix: a complex picture emerges. J. Cell Sci. 122, 4409-4417 (2009
63. Ilani T., et al. A secreted disulfide catalyst controls extracellular matrix composition and function. Science 341, 74-76 (2013
64. Vainionpaa N., Lehto V. P., Tryggvason K. & Virtanen I.α 4 chain laminins are widely expressed in renal cell carcinomas and have a de-adhesive function. Lab. Invest. 87, 780-791 (2007
65. Jemal A., et al. Global cancer statistics. CA Cancer J. Clin. 61, 69-90 (2011
66. Ali S. & Coombes R. C. Endocrine-responsive breast cancer and strategies for combating resistance. Nat. Rev. Cancer 2, 101-112 (2002
67. Ponomarev V., et al. A novel triple-modality reporter gene for whole-body fluorescent bioluminescent and nuclear noninvasive imaging. Eur. J. Nucl. Med. Mol. Imaging 31, 740-751 (2004
68. Hickson J., et al. Noninvasive molecular imaging of apoptosis in vivo using a modified firefly luciferase substrate Z-DEVD-aminoluciferin. Cell Death Differ. 17, 1003-1010 (2010
69. Gazdar A. F., et al. Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. Int. J. Cancer. 78, 766-774 (1998
70. Li Q., Birkbak N. J., Gyorffy B., Szallasi Z. & Eklund A. C. Jetset: selecting the optimal microarray probe set to represent a gene. BMC Bioinformatics 12, 474 (2011